Lucy Mastrandrea
Pediatric Endocrinology · Buffalo, NYNPI 1760565105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 24.7% of the total. 2025 is the largest year on record at $642, 5.4 times the $118 reported in 2019.
Across 19 payments — averaging $82.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$385
- Biomarin Pharmaceutical Inc.$366
- Medtronic$258
- Insulet Corporation$178
- Sequel Med Tech, LLC$137
- Sanofi-aventis U.S. LLC$123
- plus $111 from 4 others
Across 1,553 payments — averaging $634.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$557K
- Rhythm Pharmaceuticals, Inc.$144K
- Astrazeneca UK Limited$134K
- Eli Lilly$73K
- Dompe Farmaceutici S.p.a.$62K
- Sanofi US Services Inc.$15K
What the payments were for
- Food & beverage$1,49996%
- Education$594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 4 | $385 |
| Biomarin Pharmaceutical Inc. | 3 | $366 |
| Medtronic | 2 | $258 |
| Insulet Corporation | 2 | $178 |
| Sequel Med Tech, LLC | 1 | $137 |
| Sanofi-aventis U.S. LLC | 2 | $123 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| AbbVie | 2 | $29 |
| SK Life Science, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$361
- MINIMED 780G$258
- TWIIST$137
- Vimizim$121
- VOXZOGO 1.2mg$119
- TZIELD$108
- Omnipod$105
How this compares
$1,558 in reported general payments places this provider in the 60th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Buffalo
- Kathleen BethinBuffalo$14K
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
- Angela VerardoBronx$38K
- Christopher RomeroNew York$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.